Clinical Trials Logo

Immune Dysfunction clinical trials

View clinical trials related to Immune Dysfunction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05367986 Completed - Sepsis Clinical Trials

Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis

EAIm-sepsis
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study was to investigate the biochemical and clinical effects of electro-acupuncture in patients with sepsis.

NCT ID: NCT03364699 Completed - Immune Dysfunction Clinical Trials

Fish Oils and Soybean Lecithin Supplementation Modulate Immune Function in Runners

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study was evaluate the comparative effects of FO rich in EPA (FO-EPA) and FO rich in DHA (FO-DHA) on inflammation and neutrophil properties after a prolonged and strenuous exercise. The effect of soybean lecithin on the same parameters and conditions also was evaluated.

NCT ID: NCT02981992 Completed - Immune Dysfunction Clinical Trials

T Regulatory Cells in Hemodialysis Patients: Observational Study

Start date: February 2011
Phase: N/A
Study type: Observational

In this observational study, the investigators evaluated the Treg number and function in a population of patients undergoing hemodialysis (HD). In particular, the investigators considered the relationship of Treg cell status with the different HD modalities and clinical parameters.

NCT ID: NCT02053740 Completed - Immune Dysfunction Clinical Trials

Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial

Start date: January 2013
Phase: Phase 4
Study type: Interventional

Participants and study design: Subjects were recruited and selected for uremic patients on maintenance hemodialysis (HD) who informed us of their interest in the investigators study and were mentally capable to give an informed written consent and willing to comply with study requirements. The inclusion criteria were 18 years or older, with at least 3 months maintenance HD. The exclusion criteria were malignancy, acute infection, gastrointestinal bleeding, pregnancy, and inability to comply with the requirements of study. 69 respondents were enrolled in this trial. A single-center quasi-randomized controlled clinical trial was designed based on the patients in the care of one attending physician. Eligible subjects were allocated to study and control group, and the basic characteristics between the experimental group and control group were matched. There was no significant difference regarding gender, aged, education level, comorbidities between these two groups. The experimental group was treated with Ren Shen Yang Rong Tang (R-S-Y-R-T) combined routine western medicine, and the control group was treated with WM alone. The experimental group had 32 respondents and the control group had 37 respondents. The duration of use of R-S-Y-R-T was 6 months. Finally, there were 27 patients in the experimental group and 32 patients in the control group completed the study. Blood investigation, including biochemical profiles and inflammatory markers were checked at intervals 0, 2, 4 and 6 months form routine HD. The questionnaire, for the assessment of quality of life (QOL) was evaluated at interval 0, and 6 months.

NCT ID: NCT01821820 Completed - Inflammation Clinical Trials

Pistachios, Performance, Metabolomics

Start date: March 2013
Phase: N/A
Study type: Interventional

Ingestion of 3 ounces of pistachio nuts per day for two weeks before and the day of cycling intensely for 75 kilometers will support substrate utilization during exercise (as determined through metabolomics) and improve performance compared to water only, and attenuate inflammation, oxidative stress, and immune dysfunction during 24 hours of recovery.